Background and aims: This survey aimed to compare actual lifestyle factors and QOL between Japanese IBD patients and healthy Japanese controls, by questionnaire using an internet-web system. Methods: Through the internet-web system, we asked 464 patients with Crohn's disease [CD], 360 patients with ulcerative colitis [UC], and 4100 healthy controls to answer a questionnaire including an eight-item short-form health survey . The survey was conducted until data had been accumulated from the predetermined numbers of patients [120 patients each with CD and UC] and healthy controls [240 subjects]. Results: QOL assessment by SF-8 revealed scores for six of the eight subscale items and the summary score for the mental component to be significantly lower in the CD and UC groups than in controls. There was a significant negative correlation between each SF-8 score and the degree of CD and UC symptoms. The marriage rate in adult patients was significantly lower in the CD than in the UC group or the controls. The mean annual income and the employment rate were significantly lower in the CD than in the UC group or the controls. CD patients receiving biologicals were more frequently satisfied with the efficacy of treatment than UC patients were with their treatment regimens [56% vs 29%]. Conclusions: Actual lifestyle factors and QOL appear to be impaired in Japanese patients with IBD, especially those with CD. The subjective efficacy of biologicals might be greater in CD than in UC.
Introduction
Inflammatory bowel diseases [IBD] including Crohn's disease [CD] and ulcerative colitis [UC] are chronic and intractable inflammatory conditions of the bowel of unknown aetiology. 1 Since IBD predominantly occurs in adolescents and persists for prolonged periods, quality of life [QOL] for patients presumably deteriorates because of ongoing and recurrent symptoms, such as diarrhoea and abdominal pain. 2, 3 Although an annual increase in the number of patients with IBD has been documented in Japan, 4, 5 QOL in IBD has not as yet been adequately investigated.
Since the introduction of biologicals such as infliximab [IFX] 6,7 and adalimumab [ADA] , 8, 9 the therapeutic strategy for IBD has changed dramatically. 10, 11 Even though the efficacy of biologicals for IBD has been rigorously investigated with respect to the objective clinical activity of these diseases and the degree of mucosal healing, the subjective efficacy of such medications has not been investigated in detail.
With the widespread use of the internet, web-based surveys have become common for the assessment of QOL in patients with various diseases. 12, 13, 14, 15 The web-based internet surveys are convenient, and it has been presumed that they can minimise bias originating from physicians' interactions, thereby resulting in accurate assessment of QOL in chronic and intractable diseases such as IBD. 14, 15 In order to investigate global QOL status in Japanese patients with CD and UC, and to examine possible contribution of biologicals on the QOL of the patients, we conducted a web-based survey of Japanese patients with IBD.
Materials and Methods

Survey instruments
During the period of February 7-11, 2014, we conducted an investigation using the internet to survey IBD patients in Japan. This investigation has been dubbed the 3I survey based on the abbreviation for Internet, Investigation, and IBD. Employing an internet-based web site, we sent e-mails requesting responses to our questionnaire survey to 464 patients with CD, 360 patients with UC and 4 100 control subjects with neither UC nor CD, with a notion that the responders would be guaranteed small amount of incentives. All of the patients and the control subjects had previously been registered in a database maintained by the Cross Marketing Corporation, Tokyo, Japan. Predetermined target sample sizes for final analyses were 120 each for CD and UC, and 240 for controls. The sample sizes for CD and UC were predetermined on the basis of the numbers of registered populations with the diseases and the general response rate in other web-based internet surveys. The sample size of controls was calculated as sum of the predetermined sample sizes for CD and UC.
CD and UC subjects were regarded as having the disease on the basis of personal statements. Similarly, we regarded control subjects as being healthy, based on personal statements. After informed consent as to the purpose of the survey and the incentives, online agreements for participation in the study and for publication of the results were obtained from each subject.
The questions covered age, gender, marital status, income, smoking, and an eight-item short form-health survey , 16, 17 which was used for the assessment of QOL. Generally, the SF-8 consists of eight components and it generates two summary scores and eight subscale scores, with higher scores indicating better QOL. The physical summary component [PSC] 
Statistical analysis
Statistical analyses were performed using the chi-square test or Fisher's exact test for categorical variables. Student's t test, the MannWhitney U-test or the KruskalWallis test was used for comparisons of parametric variables. Spearman's rank correlation test was used for examining correlations between SF-8 scores and symptoms. Probabilities less than < 0.05 were considered to be statistically significant.
Results
Demographics of patients with IBD and of controls
We obtained responses from 240 patients with IBD [120 each comprising the CD and UC groups] and 240 healthy controls. Since there were no invalid responses, we included all responses in the data analysed. Table 2 compares the socioeconomic status of subjects except for those less than 20 years of age, students, and housewives. Whereas neither age nor gender differed among CD, UC, and controls, the annual income was significantly lower and the unemployment rate was significantly higher in the CD than in the UC group or the controls [p < 0.0005 for income and p = 0.0001 for unemployment rate]. , both of which belong to the PCS category, were significantly lower in the CD than in the UC group or the controls. In contrast, all four items comprising the MCS were significantly lower in both the CD and the UC group than in controls. The symptoms of the 240 patients with IBD were graded as poor or extremely poor by 41, fair by 50, relatively good by 111, and excellent by 38 of the patients. Table 3 shows correlations between symptom grades and SF-8 scores. As shown in the table, all eight items of the SF-8, PCS, and MCS showed significant correlations with symptom grades. Among these scores, GH showed the highest correlation followed by PCS. Figure 2 compares disturbances in daily activities between patients with CD and those with UC. As shown in the figure, CD patients experienced disturbances in food intake, exercise, travel, and work/school more frequently than those with UC. Table 4 shows the treatments for IBD. Whereas elemental diet was more frequently used and immunomodulators were less frequently used in CD than in UC patients, administrations of 5-aminosalicylates and steroids did not differ between these two groups. The proportion of patients given biologicals was significantly higher in the CD [50%] than in the UC [11%] group [p < 0.0001]. When CD [n =95] and UC [n = 28] patients treated with biologicals were compared, the grade of satisfaction was significantly higher in the former; 29% of patients with UC reported that they were satisfied with biologicals, whereas the rate was 56% in patients with CD [p = 0.0172] [ Figure 3 ]. In each group, however, the proportion of patients satisfied with biologicals did not differ between patients treated with IFX and those given ADA.
QOL indices
Biological use in IBD
Discussion
We conducted a web-based survey of IBD patients and healthy subjects for the purpose of assessing their QOL and investigating the actual treatment status of IBD in Japan. The survey results demonstrated that Japanese patients with IBD had significantly lower QOL than healthy subjects, and that patients with CD tended to have poorer QOL than those with UC. We also found that the subjective efficacy of biologicals differed between CD and UC.
The Inflammatory Disease Questionnaire [IBDQ] 18 is a commonly applied tool for the assessment of QOL in patients with IBD. Since the IBDQ is not appropriate for the assessment of QOL in healthy controls and it is composed of detailed enquiries, we instead used SF-8, which is more easily applicable than the IBDQ for webbased surveys. Almadani et al. previously conducted a web-based survey in adolescent patients with CD and UC employing the SF-12 and the simplified IBDQ [SIBDQ], both of which are relatively simple procedures for the assessment of QOL. They found that patients with IBD suffered disturbances in both schoolwork and QOL. 19 To date, however, there have been no other web-based surveys comparing QOL among CD, UC, and healthy controls.
Even though we applied a simple five-scale grading system for the assessment of clinical symptoms, we identified a strong correlation between the grade of symptoms and each score for the SF-8 items.
Such an association between clinical symptoms and QOL would appear to be reasonable, and was previously confirmed in web-internet surveys by Kappelman et al. 20 and Long et al., 21 in which the IBDQ was applied. The present survey also revealed lower marriage and employment rates and lower annual incomes in IBD patients than in the healthy population. In a web-based survey conducted in The Netherlands by van der Valk et al., patients with CD were found to have higher levels of disability in work when compared with the nationally standardised data of the general population. 22 This difference in socioeconomic status would presumably be a consequence of the difference in long-term prognosis between UC and CD. Even though both diseases have an intractable clinical course, CD is characterised by more progressive complications such as stenoses and fistula formations 23, 24, 25, 26 and, eventually, more frequent requirements for surgery. 26, 27, 28, 29 The significantly attenuated daily activities including meals, movement, travel, work, and studying in CD subjects seem to be a consequence of such complications. Furthermore, the frequent application of elemental diets for Japanese patients with CD 30, 31 may have contributed to disturbance in meal activity. Even though more than 50% of patients with CD in Japan are receiving treatment with IFX or ADA, our survey revealed that most of the IBD patients in Japan do not have concerns regarding the cost of treating these diseases. This extraordinarily high rate of biologicals use is supported by a governmental grant for intractable diseases from the Japanese Ministry of Health, Labour and Welfare. As a consequence, patients with IBD and their attending physicians do not apparently have serious concerns with regard to the cost of medications. In contrast, the web-based survey conducted in The Netherlands by van der Valk found that medication cost accounted for most of the expenses incurred in the management of IBD and, in fact, the cost for patients receiving biologicals was particularly high. 32 With regard to patient satisfaction with the efficacy of treatment, there was an obvious difference in responses between patients with CD and those with UC. This was especially the case for biologicals, with which UC patients were less satisfied than those with CD. The results of large-scale prospective clinical trials for IFX and ADA have shown that there is a trend towards lower rates of induction and maintenance of remission in UC than in CD, and this is especially the case for ADA. 6, 7, 8, 9, 33, 34, 35, 36, 37 Whereas we are unable to directly compare efficacies between any two trials, our present results suggest that a biological, either IFX or ADA, is not as subjectively efficacious in UC as in CD. Differences in the significance of TNF-α in the perpetuation of inflammation may account for this discrepancy in the subjective efficacy of biologicals between the CD and UC patients responding to our survey. 38, 39 This study has several limitations. First, the responses may not be entirely representative of the mental and physical status of the study participants, since they were obtained through a web-based survey. Direct contact with the subjects might be more appropriate for the assessment of QOL status. Conversely, the web-based survey format with no contact may better reflect the actual conditions of the study population since subjective responses to an actual interviewer are eliminated. This is supported by the consistency in patients' responses in other web-based surveys examining IBD. 40, 41 Second, our IBD subjects and controls were different in gender distribution. We believe that such gender difference may be a consequence of the epidemiology of IBD in an Asian population, since males are predominant in Asian IBD patients. 5, 42, 43 In this respect, age-and sex-matched case-control studies should have been more appropriate. Nevertheless, we did not find any gender difference in the SF-8 scores of our CD and UC subjects [data not shown]. Third, the study population of the present investigation may not be representative of Japanese patients with IBD in general. However, such bias appears to have had minimal impact on our results, because the gender balance and age distribution of the subjects were similar to those of the Japanese population as a whole and those of IBD patients. 5 In conclusion, our present survey demonstrated impaired QOL of Japanese patients with IBD. We were also able to confirm a close association between QOL and symptoms, highlighting the importance of symptom amelioration in the management of IBD. Furthermore, the subjective efficacy of anti-TNFα antibodies appears to differ between UC and CD. The correlation of QOL with the subsequent clinical outcome seems to be another issue which needs to be investigated. 
